These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 26225229)

  • 21. Pathogenesis, diagnosis and treatment of systemic amyloidosis.
    Pepys MB
    Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):203-10; discussion 210-1. PubMed ID: 11260801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of genetically altered mice to study the role of serum amyloid P component in amyloid deposition.
    Maeda S
    Amyloid; 2003 Aug; 10 Suppl 1():17-20. PubMed ID: 14640037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma kinetics of 125I-labelled amyloid P component in beta 2M amyloidosis: a possible approach to quantitate disease activity.
    Zingraff J; Caillat-Vigneron N; Ureña P; Gagné ER; Bererhi L; Moretti JL; Bardin T; Drüeke TB
    Nephrol Dial Transplant; 1995; 10(2):223-9. PubMed ID: 7753457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative high-resolution microradiographic imaging of amyloid deposits in a novel murine model of AA amyloidosis.
    Wall JS; Kennel SJ; Paulus MJ; Gleason S; Gregor J; Baba J; Schell M; Richey T; O'Nuallain B; Donnell R; Hawkins PN; Weiss DT; Solomon A
    Amyloid; 2005 Sep; 12(3):149-56. PubMed ID: 16194869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in the acute phase responses of serum amyloid P-component (SAP) and C3 to injections of casein or bovine serum albumin in amyloid-susceptible and -resistant mouse strains.
    Baltz ML; Gomer K; Davies AJ; Evans DJ; Klaus GG; Pepys MB
    Clin Exp Immunol; 1980 Feb; 39(2):355-60. PubMed ID: 7389204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic blockade of interleukin-6 by tocilizumab in the management of AA amyloidosis and chronic inflammatory disorders: a case series and review of the literature.
    Lane T; Gillmore JD; Wechalekar AD; Hawkins PN; Lachmann HJ
    Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S46-53. PubMed ID: 26120866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulation of the major circulating precursors of proteins deposited in secondary amyloidosis by a recombinant mouse interleukin-1 receptor antagonist.
    Grehan S; Herbert J; Whitehead AS
    Eur J Immunol; 1997 Oct; 27(10):2593-9. PubMed ID: 9368615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concentration of serum amyloid P component in the CSF as a possible marker of cerebral amyloid deposits in Alzheimer's disease.
    Hawkins PN; Rossor MN; Gallimore JR; Miller B; Moore EG; Pepys MB
    Biochem Biophys Res Commun; 1994 Jun; 201(2):722-6. PubMed ID: 7516157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunotherapy in systemic primary (AL) amyloidosis using amyloid-reactive monoclonal antibodies.
    Solomon A; Weiss DT; Wall JS
    Cancer Biother Radiopharm; 2003 Dec; 18(6):853-60. PubMed ID: 14969598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SAP: structure, function, and its roles in immune-related diseases.
    Xi D; Luo T; Xiong H; Liu J; Lu H; Li M; Hou Y; Guo Z
    Int J Cardiol; 2015; 187():20-6. PubMed ID: 25828303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein.
    Gillmore JD; Lovat LB; Persey MR; Pepys MB; Hawkins PN
    Lancet; 2001 Jul; 358(9275):24-9. PubMed ID: 11454373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum amyloid P component-DNA complexes are decreased in systemic lupus erythematosus. inverse association with anti-dsDNA antibodies.
    Voss A; Nielsen EH; Svehag SE; Junker P
    J Rheumatol; 2008 Apr; 35(4):625-30. PubMed ID: 18278838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic and therapeutic approach of systemic amyloidosis.
    Hazenberg BP; van Gameren II; Bijzet J; Jager PL; van Rijswijk MH
    Neth J Med; 2004 Apr; 62(4):121-8. PubMed ID: 15255082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical identification of amyloid, using an anti-human serum amyloid P component (SAP) antibody, is possible in ruminants but not in dogs and cats.
    Hartig W; Leifsson PS; Nielsen OL
    J Vet Med A Physiol Pathol Clin Med; 2005 Nov; 52(9):447-53. PubMed ID: 16268955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Classification of amyloidosis: immunohistochemistry versus the potassium permanganate method in differentiating AA from AL amyloidosis.
    Janssen S; Elema JD; van Rijswijk MH; Limburg PC; Meijer S; Mandema E
    Appl Pathol; 1985; 3(1-2):29-38. PubMed ID: 3915945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crystal structure of a decameric complex of human serum amyloid P component with bound dAMP.
    Hohenester E; Hutchinson WL; Pepys MB; Wood SP
    J Mol Biol; 1997 Jun; 269(4):570-8. PubMed ID: 9217261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic removal of amyloid deposits in cutaneous amyloidosis by localised intra-lesional injections of anti-amyloid antibodies.
    Clos AL; Lasagna-Reeves CA; Wagner R; Kelly B; Jackson GR; Kayed R
    Exp Dermatol; 2010 Oct; 19(10):904-11. PubMed ID: 20626464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction.
    Bijl M; Bootsma H; Van Der Geld Y; Limburg PC; Kallenberg CG; Van Rijswijk MH
    Ann Rheum Dis; 2004 Jul; 63(7):831-5. PubMed ID: 15194579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies of the in vivo synthesis and catabolism of serum amyloid P component (SAP) in the mouse.
    Baltz ML; Dyck RF; Pepys MB
    Clin Exp Immunol; 1985 Jan; 59(1):235-42. PubMed ID: 3882285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Demonstration of amyloid A (AA) protein and amyloid P component (AP) in deposits of systemic amyloidosis associated with renal adenocarcinoma.
    Hind CR; Tennent GA; Evans DJ; Pepys MB
    J Pathol; 1983 Feb; 139(2):159-66. PubMed ID: 6338184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.